MDxHealth SA annual ebitda
2019
2020
2021
2022
2023
MDxHealth SA's calculated EBITDA was −$25.0M for fiscal 2023.
View full MDxHealth SA company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$25.0M | $12.0M | — |
| 2022 | 2022-12-31 | −$36.9M | −$11.0M | — |
| 2021 | 2021-12-31 | −$26.0M | −$364,000 | — |
| 2020 | 2020-12-31 | −$25.6M | $16.0M | — |
| 2019 | 2019-12-31 | −$41.6M | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Across the available reported history, MDxHealth SA's ebitda increased from −$36.9M to −$25.0M, a change of $12.0M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MDxHealth SA filings at SEC.gov ↗